Prosight Management, LP
- SEC CIK
- 0001617201
- Latest filing
- Aug 14, 2026
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 41
- −5 vs. Q2 2024
- Portfolio value
- $394.4M
- +$59.8M (+17.9%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ADCTADC Therapeutics SA | SHS | 9,636,237 | $30.4M | 7.7% | +66,237+0.7% | Added | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 1,028,843 | $29.6M | 7.5% | −321,137−23.8% | Reduced | History |
| BBIOBridgeBio Pharma, Inc. | COM | 1,086,810 | $27.7M | 7.0% | +286,810+35.9% | Added | History |
| ABCLAbCellera Biologics Inc. | COM | 9,079,539 | $23.6M | 6.0% | +6,726,906+285.9% | Added | History |
| MGTXMeiraGTx Holdings plc | COM | 4,900,570 | $20.4M | 5.2% | +547,870+12.6% | Added | History |
| ROIVRoivant Sciences Ltd. | SHS | 1,721,512 | $19.9M | 5.0% | −278,488−13.9% | Reduced | History |
| STTKShattuck Labs, Inc. | COM | 5,678,726 | $19.8M | 5.0% | +1,008,726+21.6% | Added | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 465,825 | $18.2M | 4.6% | +151,025+48.0% | Added | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 165,602 | $17.9M | 4.5% | −4,398−2.6% | Reduced | History |
| MCKMcKesson Corp | Stock | 35,822 | $17.7M | 4.5% | +35,822 | New | History |
| KURAKura Oncology, Inc. | COM | 705,109 | $13.8M | 3.5% | +75,209+11.9% | Added | History |
| SDGRSchrodinger, Inc. | COM | 700,000 | $13.0M | 3.3% | +330,739+89.6% | Added | History |
| ZYMEZymeworks Inc. | COM | 917,599 | $11.5M | 2.9% | −262,401−22.2% | Reduced | History |
| ACCDAccolade, Inc. | COM | 2,801,598 | $10.8M | 2.7% | +1,312,073+88.1% | Added | History |
| DXCMDexcom Inc | COM | 160,000 | $10.7M | 2.7% | +110,683+224.4% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 554,103 | $10.7M | 2.7% | +2,559+0.5% | Added | History |
| IMVTImmunovant, Inc. | COM | 370,000 | $10.5M | 2.7% | +45,000+13.8% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 192,700 | $10.2M | 2.6% | −37,300−16.2% | Reduced | History |
| JANXJanux Therapeutics, Inc. | COM | 205,000 | $9.31M | 2.4% | +205,000 | New | History |
| PRTAProthena Corp Public Ltd Co | SHS | 483,467 | $8.09M | 2.1% | +196,541+68.5% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 62,000 | $7.14M | 1.8% | +35,000+129.6% | Added | History |
| ERASErasca, Inc. | COM | 1,984,010 | $5.42M | 1.4% | −765,990−27.9% | Reduced | History |
| HAEHaemonetics Corp | COM | 65,000 | $5.22M | 1.3% | +65,000 | New | History |
| LIVNLivaNova PLC | SHS | 90,000 | $4.73M | 1.2% | +90,000 | New | History |
| COGTCogent Biosciences, Inc. | COM | 410,830 | $4.44M | 1.1% | −89,170−17.8% | Reduced | History |
| BPMCBlueprint Medicines Corp | COM | 47,100 | $4.36M | 1.1% | +47,100 | New | History |
| TECXTectonic Therapeutic, Inc. | COM | 137,614 | $4.17M | 1.1% | +70,153+104.0% | Added | History |
| CTMXCytomX Therapeutics, Inc. | COM | 3,022,109 | $3.57M | 0.9% | +3,022,109 | New | History |
| SGHTSight Sciences, Inc. | COM | 531,222 | $3.35M | 0.8% | +531,222 | New | History |
| VKTXViking Therapeutics, Inc. | COM | 48,000 | $3.04M | 0.8% | −67,000−58.3% | Reduced | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 159,369 | $2.94M | 0.7% | +159,369 | New | History |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 130,000 | $2.68M | 0.7% | +130,000 | New | History |
| MURAMural Oncology plc | ORD SHS | 570,620 | $1.79M | 0.5% | +95,162+20.0% | Added | History |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 208,200 | $1.73M | 0.4% | +208,200 | New | History |
| VINCVincerx Pharma, Inc. | COM NEW | 2,206,505 | $1.58M | 0.4% | −281,913−11.3% | Reduced | History |
| RNTXRein Therapeutics, Inc. | COM NEW | 372,157 | $1.32M | 0.3% | +107,157+40.4% | Added | History |
| SEMSelect Medical Holdings Corp | COM | 26,065 | $908.9K | 0.2% | +26,065 | New | History |
| OVIDOvid Therapeutics Inc. | COM | 729,208 | $860.5K | 0.2% | −345,792−32.2% | Reduced | History |
| IMNMImmunome Inc. | COM | 39,135 | $572.2K | 0.1% | −25,865−39.8% | Reduced | History |
| IMRXImmuneering Corp | CLASS A COM | 190,000 | $473.1K | 0.1% | −360,000−65.5% | Reduced | History |
| ACHCAcadia Healthcare Company, Inc. | COM | 5,666 | $359.3K | 0.1% | +5,666 | New | History |
Options (4)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| iShares Tr464287955 | PUT | $6.41M | – |
| Cassava Sciences Inc14817C957 | PUT | $4.38M | – |
| Corvel Corp221006959 | PUT | $915.3K | – |
| Shattuck Labs Inc82024L953 | PUT | – | $302.9K |
Sold out since Q2 2024 (17)
Positions held at the end of Q2 2024 that are gone from this filing.
| Security | Class | Shares in Q2 2024 | Value in Q2 2024 | % of portfolio in Q2 2024 | History |
|---|---|---|---|---|---|
| KELYAKelly Services Inc | CL A | 492,340 | $10.5M | 3.2% | History |
| ALKSAlkermes plc. | SHS | 275,000 | $6.63M | 2.0% | History |
| KIDSOrthopediatrics Corp | COM | 200,216 | $5.76M | 1.7% | History |
| OPCHOption Care Health, Inc. | COM NEW | 205,000 | $5.68M | 1.7% | History |
| RLAYRelay Therapeutics, Inc. | COM | 385,000 | $2.51M | 0.8% | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 398,700 | $2.46M | 0.7% | History |
| CVSCVS Health Corp | Stock | 40,000 | $2.36M | 0.7% | History |
| MDTMedtronic plc | Stock | 30,000 | $2.36M | 0.7% | History |
| INSPInspire Medical Systems, Inc. | COM | 14,000 | $1.87M | 0.6% | History |
| FNAParagon 28, Inc. | COM | 261,400 | $1.79M | 0.5% | History |
| UHSUniversal Health Services Inc | CL B | 9,373 | $1.73M | 0.5% | History |
| PRVAPrivia Health Group, Inc. | COM | 96,065 | $1.67M | 0.5% | History |
| ADUSAddus HomeCare Corp | COM | 12,500 | $1.45M | 0.4% | History |
| LENZLENZ Therapeutics, Inc. | COM | 59,542 | $1.03M | 0.3% | History |
| TXG10x Genomics, Inc. | CL A COM | 49,021 | $953.5K | 0.3% | History |
| BMEABiomea Fusion, Inc. | COM | 124,377 | $559.7K | 0.2% | History |
| KZRKezar Life Sciences, Inc. | COM | 56,080 | $33.6K | <0.1% | History |